Prof. Christoph A. Nienaber new member of Medical Advisory Board of PHTS Telemedizin

SHL TeleMedicine Ltd.PHTS Telemedizin, the wholly owned German subsidiary of SHL Telemedicine Ltd. (SWX:SHLTN), has appointed Prof. Dr. med. Christoph A. Nienaber to its Medical Advisory Board. The renowned cardiologist strengthens PHTS Telemedizin with his cardiological competence and profound know-how in the implementation of telemedicine.

Prof. Nienaber holds the chair of cardiology at the University of Rostock and has been the head of the cardiological clinic for the last seven years. He has been a leading figure for several years in the structuring of telemedicine support programmes within the framework of integrated care and is recognized as one of the pioneers in the field. He is already working closely with PHTS Telemedizin. "Coronary heart diseases are a core field for the application of telemedicine and I am looking forward to using my experience to support the colleagues at PHTS Telemedizin with advice and action."

Personal HealthCare Telemedicine Services GmbH (PHTS), established in Düsseldorf in 2001, is a wholly owned subsidiary of SHL Telemedicine. PHTS Telemedizin (www.phts.de) combines innovative telemedicine solutions which have been proven in practice with well-founded medical-technical know-how. PHTS (www.phts.de) therefore holds a leading position throughout Germany in the field of cardiological telemedicine.

Related news article:

About SHL TeleMedicine
SHL TeleMedicine Ltd. is a leading provider and developer of advanced personal telemedicine solutions to individuals and to the healthcare community. As a provider of remote health services in cardiology and in other medical areas, SHL maintains business operations in the US, Europe and Israel. SHL is listed on the SWX Swiss Exchange, symbol SHLTN. For more information see www.shl-telemedicine.com.

Most Popular Now

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

New AI Approach Paves Way for Smarter T-…

Researchers have harnessed the power of artificial intelligence (AI) to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...